Table 2.
Cardiovascular and overall outcomes in patients on the basis of TG/HDL-C quintiles
| ALL | TG/HDL-C 1° QUINTILE | TG/HDL-C 2° QUINTILE | TG/HDL-C 3° QUINTILEE | TG/HDL-C 4° QUINTILE | TG/HDL-C 5° QUINTILE | p | |
|---|---|---|---|---|---|---|---|
| N | 18,694 | 3778 | 3728 | 3676 | 3649 | 3863 | |
| ALL CAUSE MORTALITY, % | 14.2 | 10.9 | 14.8 | 15.8 | 16.2 | 17 | < 0.0001 |
| NON FATAL MI, % | 2.2 | 0.7 | 1.4 | 2.1 | 2.7 | 3.5 | < 0.0001 |
| FATAL MI, % | 2.2 | 1.5 | 1.9 | 2.3 | 2.4 | 3.1 | < 0.0001 |
| NON FATAL CBV EVENTS, % | 1.8 | 0.7 | 1.4 | 1.7 | 2.4 | 2.8 | < 0.0001 |
| FATAL CBV EVENTS, % | 1.9 | 1.6 | 2.2 | 1.8 | 1.8 | 2 | 0.477 |
| NON FATAL HEART FAILURE, % | 1.4 | 0.7 | 1.1 | 1.7 | 1.7 | 1.9 | < 0.0001 |
| FATAL HEART FAILURE, % | 2.6 | 1.6 | 2.9 | 3 | 3 | 2.5 | < 0.0001 |
| CV MORTALITY, % | 7.5 | 4.9 | 7.2 | 7.6 | 8.5 | 9 | < 0.0001 |
Abbreviations: CBV cerebro-vascular events, CV cardiovascular, MI myocardial infarction